Steffen Jørgensen

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Venues

Basic & clinical pharmacology & toxicology

Scientific reports

Pharmaceuticals (Basel, Switzerland)

Roskilde Universitet (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Roskilde Universitet Dec 01 2012 - Dec 01 2016

Denmark

PHD :: Department of Science and Environment

Aarhus Universitet Sep 01 1998 - May 01 2006

Denmark

MSC :: Department of Molecular Biology

Publications

Morten Baltzer Houlind, Luise Hansen, Esben Iversen, Henrik Berg Rasmussen, Jens Borggaard Larsen, Steffen Jørgensen, Kim Peder Dalhoff, Per Damkier, Anne B Walls, Charlotte Vermehren, Trine Rune Høgh Andersen, Thomas Kallemose, Lona Christrup, Niels Westergaard
Pharmacogenetic testing of CYP2D6, CYP2C19 and CYP2C9 in Denmark: Agreement between publicly funded genotyping tests and the subsequent phenotype classification. Basic & clinical pharmacology & toxicology (2024)
Morten Baltzer Houlind, Luise Hansen, Esben Iversen, Henrik Berg Rasmussen, Jens Borggaard Larsen, Steffen Jørgensen, Kim Peder Dalhoff, Per Damkier, Anne B Walls, Charlotte Vermehren, Trine Rune Høgh Andersen, Thomas Kallemose, Lona Christrup, Niels Westergaard
Pharmacogenetic testing of CYP2D6, CYP2C19 and CYP2C9 in Denmark: Agreement between publicly funded genotyping tests and the subsequent phenotype classification. Basic & clinical pharmacology & toxicology 134 (5) (2024)
Steffen Jørgensen, Thorsten Brodersen, Ole Birger Vesterager Pedersen, Niels Westergaard
Distribution of the cytochrome P450 *alleles for CYP2C9 and CYP2C19 in a cohort of the Danish Blood Donor Study determined by using the Illumina Infinium Global Screening Array. Basic & clinical pharmacology & toxicology 135 (2) (2024)
Steffen Jørgensen, Thorsten Brodersen, Ole Birger Vesterager Pedersen, Niels Westergaard
Distribution of the cytochrome P450 *alleles for CYP2C9 and CYP2C19 in a cohort of the Danish Blood Donor Study determined by using the Illumina Infinium Global Screening Array. Basic & clinical pharmacology & toxicology (2024)
Steffen Jørgensen, Thorsten Brodersen, Ole Birger Vesterager Pedersen, Niels Westergaard
Distribution of the cytochrome P450 *alleles for CYP2C9 and CYP2C19 in a cohort of the Danish Blood Donor Study determined by using the Illumina Infinium Global Screening Array. Basic & clinical pharmacology & toxicology 135 (2) (2024)
Morten Baltzer Houlind, Luise Hansen, Esben Iversen, Henrik Berg Rasmussen, Jens Borggaard Larsen, Steffen Jørgensen, Kim Peder Dalhoff, Per Damkier, Anne B Walls, Charlotte Vermehren, Trine Rune Høgh Andersen, Thomas Kallemose, Lona Christrup, Niels Westergaard
Pharmacogenetic testing of CYP2D6, CYP2C19 and CYP2C9 in Denmark: Agreement between publicly funded genotyping tests and the subsequent phenotype classification. Basic & clinical pharmacology & toxicology 134 (5) (2024)
Jens Borggaard Larsen, Steffen Jørgensen
Simple and Robust Detection of CYP2D6 Gene Deletions and Duplications Using CYP2D8P as Reference. Pharmaceuticals (Basel, Switzerland) 15 (2) (2022)
Steffen Jørgensen, Isabella Worlewenut Paulsen, Jakob Werner Hansen, Dorte Tholstrup, Christoffer Hother, Erik Sørensen, Mikkel Steen Petersen, Kaspar Rene Nielsen, Klaus Rostgaard, Margit Anita Hørup Larsen, Peter de Nully Brown, Elisabeth Ralfkiær, Keld Mikkelsen Homburg, Henrik Hjalgrim, Christian Erikstrup, Henrik Ullum, Jesper Thorvald Troelsen, Kirsten Grønbæk, Ole Birger Pedersen
The value of circulating microRNAs for early diagnosis of B-cell lymphoma: A case-control study on historical samples. Scientific reports 10 (1) (2020)

Steffen Jørgensen.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Steffen Jørgensen